InvestLog
CGEM logo

CGEM

Cullinan Therapeutics, Inc.NASDAQHealthcare
$14.43+3.52%ClosedMarket Cap: $873.4M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-11Wedbush—Outperform—
2026-01-08HC Wainwright & Co.—Buy—
2025-12-09Wedbush—Outperform—
2025-11-20HC Wainwright & Co.—Buy—
2025-09-12HC Wainwright & Co.—Buy—
2025-09-10BTIG—Buy—
2025-08-18Morgan Stanley—Overweight—
2025-05-12UBS—Buy—
2025-04-16HC Wainwright & Co.—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-2.84$34.7M7
Sun Dec 31$-2.52$51.8M6
Mon Dec 31$-2.97$69.7M4
Tue Dec 31$-0.92$280.7M2